Activatable organic phosphorescent supramolecular assembly and preparation method and characterization method thereof

Through supramolecular assembly of aminobromophenylpyridinium derivatives and cucurbitol-8 (CB[8]), an activated water-soluble organophosphorescence probe was constructed, solving the penetration of existing probes in cell and tissues. Insufficient in sexual and specificity, efficient bioimaging and detection are achieved.

CN118931528APending Publication Date: 2024-11-12EAST CHINA UNIV OF SCI & TECH
View PDF 0 Cites 1 Cited by

Patent Information

Application Number
CN202410969051.9
Authority / Receiving Office
CN · China
Patent Type
Applications(China)
Current Assignee / Owner
Filing Date
2024-07-18
Publication Date
2024-11-12

AI Technical Summary

Technical Problem

The existing pure organic room temperature phosphorescence probes lack cell and tissue penetration and specificity due to ultraviolet excitation and short phosphorescence emission wavelengths, resulting in limited bioimaging and detection sensitivity. The lack of effective material design strategies hinders high-contrast phosphorescence imaging. and sensing applications.

Method used

By using aminobromophenylpyridinium derivatives and cucurbiturium-8 (CB[8]), a supramolecular assembly with water-soluble, activates phosphorescence emission, is constructed and embedded in the ring structure of the main unit. , regulate the wavelength and intensity of phosphorescence emission to prepare an organic phosphorescence imaging probe with excellent performance.

Benefits of technology

It has achieved water-soluble, long life and light stability. It has a good organic phosphorescence imaging probe with a maximum emission wavelength of more than 600nm. It is suitable for cellular and living biomedical applications, improving detection sensitivity and imaging resolution.

✦ Generated by Eureka AI based on patent content.

Smart Images

  • Figure CN118931528A_ABST
    Figure CN118931528A_ABST
Patent Text Reader

Abstract

The invention discloses a supramolecular assembly capable of activating organic phosphorescence as well as a preparation method and a characterization method of the supramolecular assembly. The supramolecular assembly capable of activating organic phosphorescence is constructed based on a supramolecular assembly effect between an amino bromophenyl pyridinium derivative and cucurbituride-8 (CB [8]), and an amino unit in the amino bromophenyl pyridinium derivative is used as a phosphorescence regulation site to regulate and control wavelength and intensity of phosphorescence emission. The supramolecular assembly capable of activating organic phosphorescence is water-soluble, has a water-phase phosphorescence emission characteristic, can activate the phosphorescence intensity and the service life of the supramolecular assembly by increasing the viscosity of a solution, has good specificity and stable optical properties, can realize time-resolved imaging, viscosity detection, living phosphorescence imaging and the like of cells, and can be applied to the field of fluorescence imaging. Good imaging and sensing application prospects are realized.
Need to check novelty before this filing date? Find Prior Art

Description

Technical Field

[0001] The present invention relates to the technical field of organic luminescent materials, and in particular to a supramolecular assembly capable of activating organic phosphorescence, and a preparation method, a characterization method and an application thereof. Background Art

[0002] Pure organic room temperature phosphorescence (RTP) has great potential for autofluorescence-free bioimaging and biosensing due to its long-lasting luminescence and large Stokes shift. To date, a variety of strategies have been used to construct pure organic room temperature phosphorescence (RTP) probes, such as supramolecular assembly and the formation of phosphorescent nanoparticles. However, most of the current pure organic room temperature phosphorescence (RTP) probes suffer from limited cell and tissue penetration due to their ultraviolet light excitation and short phosphorescence emission wavelength (<600nm). In addition, pure organic room temperature phosphorescence (RTP) probes usually lack specific interactions with the target, resulting in limited imaging signal-to-noise ratio and detection sensitivity. Therefore, it remains challenging to accurately visualize biological events or anatomical features of interest using organic phosphorescent imaging probes.

[0003] To circumvent this situation, utilizing activatable red / near-infrared molecular probes that exhibit phosphorescent emission becomes essential as they enable signal amplification of specific biomarkers, thereby improving the sensitivity of organic phosphorescent detection while enhancing the spatiotemporal resolution in bioimaging. However, the development of activatable red / near-infrared pure organic room temperature phosphorescent (RTP) probes mainly lacks effective material design strategies, significantly hindering high-contrast phosphorescent imaging and sensing applications.

[0004] Therefore, in order to obtain organic phosphorescent imaging probes with excellent performance, the development of a new water-soluble supramolecular luminescent material with high phosphorescence intensity, long lifetime, good photostability, low toxicity and the ability to activate organic phosphorescence will help expand the practical application of such materials. Summary of the invention

[0005] In order to solve the above technical problems, the present invention provides a supramolecular assembly with activatable organic phosphorescence and its preparation method, characterization method and application. By using an amino bromophenylpyridinium derivative with potential activatable phosphorescence emission as a guest material and cucurbituril-8 (CB[8]) as a host material for supramolecular assembly, an organic phosphorescent imaging probe with water solubility, enhanced emission intensity and lifetime can be prepared.

[0006] The specific technical solutions of the present invention include:

[0007] According to the present invention, a supramolecular assembly capable of activating organic phosphorescence is provided, wherein the supramolecular assembly capable of activating organic phosphorescence comprises cucurbituril-8 (CB[8]) as a main unit and an aminobromophenylpyridinium derivative of formula (I) as a guest unit, wherein the guest unit is embedded in a cavity in a ring structure of the main unit through supramolecular interaction to form the supramolecular assembly capable of activating organic phosphorescence.

[0008] Wherein, R1 is selected from N(Me)Boc, OMe, NHMe, OBoc, one of the group consisting of: m is selected from an integer between 0 and 20; R2 is selected from one of the group consisting of F, Cl, Br and I; and n is selected from an integer between 0 and 18.

[0009] According to the present invention, there is also provided a method for preparing a supramolecular assembly capable of activating organic phosphorescence, wherein the supramolecular assembly capable of activating organic phosphorescence comprises cucurbituril-8 (CB[8]) as a host unit and an aminobromophenylpyridinium derivative of formula (I) as a guest unit, wherein the guest unit is embedded in the cavity of the ring structure of the host unit through supramolecular interaction to form the supramolecular assembly capable of activating organic phosphorescence, and the preparation method comprises the following steps:

[0010] Step S01: providing an aminobromophenylpyridinium derivative, wherein 4-(4-bromophenyl)

[0011] A reaction mixture of 1-(3-bromopropyl)pyridin-1-ium and a phenylpyridine derivative is dissolved in acetonitrile to obtain an aminobromophenylpyridinium derivative represented by the following formula (I), and the chemical formula of the reaction is as follows:

[0012]

[0013] Wherein, R1 is selected from N(Me)Boc, OMe, NHMe, OBoc, one of the group consisting of: m is selected from an integer between 0 and 20; R2 is selected from one of the group consisting of F, Cl, Br and I; and n is selected from an integer between 0 and 18.

[0014] Step S02: dissolving the aminobromophenylpyridinium derivative and cucurbituril-8 (CB[8]) solid sample in an aqueous solution and subjecting the mixture to an ultrasonic treatment to obtain the supramolecular assembly capable of activating organic phosphorescence.

[0015] In some embodiments of the present invention, the 4-(4-bromophenyl)-1-(3-bromopropyl)pyridine

[0016] The -1-ium and phenylpyridine derivatives were dissolved in acetonitrile in a 1:1 ratio.

[0017] In some embodiments of the present invention, the aminobromophenylpyridinium derivative and the cucurbituril-8 (CB[8]) solid sample are dissolved in an aqueous solution at a ratio of 1:1.

[0018] In some embodiments of the present invention, the concentration of the amino bromophenyl pyridinium is 2.0×10 -5 M -1 , the concentration of cucurbituril-8 (CB[8]) was 0-3.0×10 -5 M -1 .

[0019] According to the present invention, a method for characterizing a supramolecular assembly capable of activating organic phosphorescence is provided, the method comprising the following steps:

[0020] Step S100A: dissolving the supramolecular assembly capable of activating organic phosphorescence as claimed in claims 1 to 4 in water to obtain an aqueous solution of the supramolecular assembly capable of activating organic phosphorescence; and

[0021] Step S200A: performing a UV-visible light absorption titration on the aqueous solution of the supramolecular assembly capable of activating organic phosphorescence to analyze an assembly mode of the supramolecular assembly capable of activating organic phosphorescence.

[0022] According to the present invention, a method for characterizing a supramolecular assembly capable of activating organic phosphorescence is provided, the method comprising the following steps:

[0023] Step S100B: dissolving the supramolecular assembly capable of activating organic phosphorescence as claimed in claims 1 to 4 in water to obtain an aqueous solution of the supramolecular assembly capable of activating organic phosphorescence; and

[0024] Step S200B: Performing a phosphorescence lifetime test on the aqueous solution of the supramolecular assembly capable of activating organic phosphorescence using a phosphorescence spectrometer to analyze a phosphorescence lifetime of the supramolecular assembly capable of activating organic phosphorescence.

[0025] In some embodiments of the present invention, the step S200B further comprises performing a phosphorescence lifetime test on the aqueous solution of the supramolecular assembly capable of activating organic phosphorescence using the phosphorescence spectrometer under viscosity variation conditions.

[0026] The present invention also relates to an application of the supramolecular assembly capable of activating phosphorescence, wherein the supramolecular assembly capable of activating organic phosphorescence is applied to cell phosphorescence imaging, two-photon phosphorescence imaging, cell viscosity detection, and in vivo phosphorescence imaging.

[0027] The present invention provides a supramolecular assembly capable of activating phosphorescence, which is used for organelle targeted imaging, cell phosphorescence imaging and sensing, and in vivo phosphorescence imaging and sensing. In addition, the supramolecular assembly capable of activating phosphorescence provided by the present invention is constructed based on the supramolecular assembly between an aminobromophenylpyridinium derivative and cucurbituril-8 (CB[8]), wherein the aminobromophenylpyridinium derivative is embedded as a guest unit in the cavity of the cyclic structure of the cucurbituril-8 (as a host unit), thereby constituting the supramolecular assembly capable of activating organic phosphorescence. The amine unit in the aminobromophenylpyridinium derivative serves as a phosphorescence regulating site to regulate the wavelength and intensity of phosphorescence emission, and the supramolecular assembly capable of activating organic phosphorescence is a new organic phosphorescent material having a maximum emission wavelength of more than 600 nm, which is non-toxic, has good biocompatibility, and can be used for biomedical applications of cells and living bodies. Furthermore, the present invention provides a method for preparing a supramolecular assembly capable of activating phosphorescence, which has a simple synthesis route, high reaction efficiency, high yield, and high industrial application prospects. Finally, the present invention provides a method for characterizing a supramolecular assembly capable of activating phosphorescence, which is used to test and analyze the assembly mode, phosphorescence intensity and lifetime of the supramolecular assembly capable of activating phosphorescence, and the application results of cell and living body phosphorescence imaging.

[0028] Further details and advantages of the invention are described with reference to the embodiments shown in the drawings. BRIEF DESCRIPTION OF THE DRAWINGS

[0029] By way of example only, some embodiments of the present invention are described herein with reference to the accompanying drawings. With specific reference now to the accompanying drawings in detail, it is emphasized that the details shown are by way of example and for the purpose of illustrative discussion of embodiments of the present invention. In this regard, the description in conjunction with the accompanying drawings makes it clear to those skilled in the art how to implement embodiments of the present invention.

[0030] In the attached picture:

[0031] Figure 1 The figure is a schematic diagram of the chemical formula for the interaction between the host unit and the guest unit of the supramolecular assembly capable of activating phosphorescence of the present invention.

[0032] Figure 2 The figure is a schematic flow chart of the method for preparing the supramolecular assembly capable of activating phosphorescence according to the present invention.

[0033] Figure 3A-3B The figure is a schematic flow chart of the method for characterizing the supramolecular assembly capable of activating phosphorescence according to the present invention.

[0034] Figure 4 Schematic diagram of the H NMR spectrum of the guest unit L1-aminobromophenylpyridinium derivative of the present invention.

[0035] Figure 5Schematic diagram of the H NMR spectrum of the guest unit L2-aminobromophenylpyridinium derivative of the present invention.

[0036] Figure 6 Schematic diagram of the absorption spectrum during the supramolecular assembly process of the guest unit L1-aminobromophenylpyridinium derivative and cucurbituril-8 (CB[8]) of the present invention.

[0037] Figure 7 Schematic diagram of the absorption spectrum during the supramolecular assembly process of the guest unit L2-aminobromophenylpyridinium derivative and cucurbituril-8 (CB[8]) of the present invention.

[0038] Figure 8 Schematic diagram of the emission spectrum during the supramolecular assembly process of the guest unit L1-aminobromophenylpyridinium derivative and cucurbituril-8 (CB[8]) of the present invention.

[0039] Fig. 9 Schematic diagram of the emission spectrum during the supramolecular assembly process of the guest unit L2-aminobromophenylpyridinium derivative and cucurbituril-8 (CB[8]) of the present invention.

[0040] Fig.10 Schematic diagram of the phosphorescence lifetime of the supramolecular assembly L1C capable of activating phosphorescence of the present invention in aqueous solution.

[0041] Fig.11 Schematic diagram of the emission spectra of the supramolecular assembly L1C capable of activating phosphorescence of the present invention in solutions with different viscosities.

[0042] Fig.12 Schematic diagram of the lifetime spectrum of the supramolecular assembly L1C capable of activating phosphorescence of the present invention in solutions with different viscosities.

[0043] Fig.13 Schematic diagram of the specific response of the phosphorescence-activatable supramolecular assembly L1C of the present invention to viscosity.

[0044] Fig.14 Schematic diagram of cell lysosome targeted imaging of the phosphorescence-activatable supramolecular assembly L1C of the present invention.

[0045] Fig.15 It is a schematic diagram of the cell viscosity detection of the phosphorescence-activatable supramolecular assembly L1C of the present invention under the action of dexamethasone and nystatin.

[0046] Fig.16 This is the cellular time-resolved imaging of the phosphorescent supramolecular assembly L1C of the present invention.

[0047] Fig.17 Schematic diagram of mouse phosphorescence imaging and fluorescence imaging of the phosphorescence-activatable supramolecular assembly L1C of the present invention. DETAILED DESCRIPTION

[0048] The following is an introduction to the specific embodiments of the phosphorescence-activatable supramolecular assembly of the present invention, its preparation method, characterization method and application in conjunction with the accompanying drawings. It should be noted that the implementation of the present invention is not limited to the following embodiments. Those skilled in the art can understand the advantages and effects of the present invention from the contents disclosed in this specification. The present invention can be implemented or applied through other different specific embodiments, and the details in this specification can also be modified and changed in various ways based on different viewpoints and applications without departing from the concept of the present invention. In addition, the drawings of the present invention are only simple schematic illustrations and are not depicted in actual size. The following embodiments will further explain the relevant technical contents of the present invention in detail, but the disclosed contents are not intended to limit the scope of protection of the present invention.

[0049] The present invention discloses a supramolecular assembly capable of activating phosphorescence, wherein the supramolecular assembly capable of activating organic phosphorescence comprises cucurbituril-8 (CB[8]) as a main unit and an aminobromophenylpyridinium derivative of formula (I) as a guest unit, wherein the guest unit is embedded in a cavity in a ring structure of the main unit through supramolecular interaction to form the supramolecular assembly capable of activating organic phosphorescence.

[0050]

[0051] Wherein, R1 is selected from N(Me)Boc, OMe, NHMe, OBoc, one of the group consisting of: m is selected from an integer between 0 and 20; R2 is selected from one of the group consisting of F, Cl, Br and I; and n is selected from an integer between 0 and 18.

[0052] See also Figure 1 , which is a schematic diagram of the chemical formula of the interaction between the host unit and the guest unit of the supramolecular assembly capable of activating phosphorescence of the present invention. The aminobromophenylpyridinium derivative of the guest unit has a chemical structure as shown in formula (I), the supramolecular assembly capable of activating organic phosphorescence has a chemical structure as shown in formula (II), and the chemical formula of the interaction is as shown in Figure 1 shown.

[0053] As used herein, the term "supramolecular" refers to supramolecular chemistry, which is a branch of chemistry that studies the interactions between molecules and the structure and function of molecular assemblies. Supramolecular chemistry focuses more on the forces between molecules, namely "the complex system formed by non-covalent bonds (such as hydrogen bonds, electrostatic interactions, van der Waals forces and π-π interactions). Supramolecular chemistry can be imagined as a high-tech Lego game, where different molecular blocks are assembled together through special "snap-on" mechanisms to form complex and functional structures. Incidentally, host-guest chemistry is a branch of supramolecular chemistry in which host molecules are combined with guest molecules or ions. One of the molecules (the host molecule) provides an appropriate cavity or space to accommodate the other molecule (the guest molecule). The two components of the complex interact through non-covalent forces (most commonly hydrogen bonding). The binding between the host and the guest can be highly selective. In this case, host-guest chemistry can be imagined as the relationship between a key and a lock: the host molecule is the lock, the guest molecule is the key, and only the right key can perfectly match the lock.

[0054] As used herein, the term "host unit" is generally a molecule with a specific shape or structure that can form a cavity or hole to accommodate the guest unit molecule.

[0055] As used herein, the term "guest unit" refers to a molecule that can be inserted into a cavity or hole of a host molecule. The guest unit molecule is bound to the host molecule through non-covalent interactions.

[0056] As used herein, the term "cucurbituril-8" refers to a molecule composed of cucurbituril monomers. Cucurbituril is a cavity structure formed by bridging sugar molecules, which can effectively accommodate various guest unit molecules. The interaction between cucurbituril and guest unit molecules is very strong, and stable complexes can be formed with guest molecules through hydrogen bonds and hydrophobic effects. Cucurbituril is named Cucurbit[n]uril according to the number of glycoluril units it contains, abbreviated as CB[n], Q[n], etc., and its Chinese name is Cucurbit[n]uril and Cucurbita[n]uril. The main products include CB[5], CB[6], CB[7], CB[8], and CB

[10] . Due to its special structure and excellent host-guest unit molecular recognition performance, cucurbituril molecules have broad application prospects, mainly including molecular reactors, drug carriers, molecular machines and switches, hydrogels, ion channels, vesicles, ion selective electrodes, etc. The CB[8[ structure in the above chemical formula is only a monomer of cucurbituril. The complete structure of cucurbituril-8 (CB[8]) is shown in the following formula (III):

[0057]

[0058] The supramolecular assembly capable of activating organic phosphorescence is constructed based on the supramolecular assembly between an aminobromophenylpyridinium derivative and cucurbituril-8 (CB[8]). The amine unit in the aminobromophenylpyridinium derivative is used as a phosphorescence regulating site to achieve the effect of regulating the wavelength and intensity of phosphorescence emission.

[0059] See also Figure 2 , Figure 2 The present invention is a schematic flow diagram of a method for preparing a supramolecular assembly capable of activating phosphorescence. The supramolecular assembly capable of activating organic phosphorescence of the present invention comprises cucurbituril-8 (CB[8]) as a main unit and an aminobromophenylpyridinium derivative of formula (I) as a guest unit, wherein the guest unit is embedded in the cavity of the ring structure of the main unit through supramolecular interaction to form the supramolecular assembly capable of activating organic phosphorescence, and the preparation method comprises the following steps:

[0060] Step S01: providing an amino bromophenyl pyridinium derivative, wherein a reaction mixture of 4-(4-bromophenyl)-1-(3-bromopropyl)pyridin-1-ium and a phenylpyridine derivative is dissolved in acetonitrile to obtain an amino bromophenyl pyridinium derivative represented by the following formula (I), and the reaction chemical formula is as follows:

[0061]

[0062] Wherein R1 is selected from N(Me)Boc, One of OMe and NHMe.

[0063] Step S02: dissolving the aminobromophenylpyridinium derivative and cucurbituril-8 (CB[8]) solid sample in an aqueous solution and subjecting the mixture to an ultrasonic treatment to obtain the supramolecular assembly capable of activating organic phosphorescence.

[0064] In more detail, in step S01, a reaction mixture of 4-(4-bromophenyl)-1-(3-bromopropyl)pyridin-1-ium (4.27mmol, 1.00g) and a phenylpyridine derivative (4.70mmol, 0.51g) was dissolved in acetonitrile (25mL) to obtain an intermediate mixture, which was stirred overnight under reflux conditions and then filtered. The solid was washed with acetonitrile (25mL×2) to obtain a white solid aminobromophenylpyridinium phenylpyridinium salt intermediate 1.

[0065] Furthermore, in step S02, the aminobromophenylpyridinium and cucurbituril-8 (CB[8]) solid samples prepared in step S01 are weighed in a molar ratio of 1:1, dissolved in ultrapure water to obtain a transition solution, and the transition solution is ultrasonically treated for 20 minutes to allow the transition solution to fully dissolve and undergo an assembly reaction, thereby obtaining an aqueous solution of a supramolecular assembly of the target product that can activate organic phosphorescence.

[0066] In some embodiments, the 4-(4-bromophenyl)-1-(3-bromopropyl)pyridin-1-ium and the phenylpyridine derivative are dissolved in acetonitrile in a ratio of 1:1.

[0067] In some embodiments, the aminobromophenylpyridinium derivative and cucurbituril-8 (CB[8]) solid sample are dissolved in an aqueous solution at a ratio of 1:1.

[0068] In some embodiments, the concentration of the amino bromophenyl pyridinium is 2.0×10 -5 M -1 , the concentration of cucurbituril-8 (CB[8]) was 0-3.0×10 -5 M -1 .

[0069] See also Figure 3A-3B , Figure 3A-3B The figure is a schematic flow chart of the method for characterizing the supramolecular assembly capable of activating phosphorescence according to the present invention.

[0070] Characterization of supramolecular assemblies of aminobromophenylpyridinium derivatives-cucurbituril

[0071] Figure 3A A method for characterizing a supramolecular assembly capable of activating organic phosphorescence, the method comprising the following steps:

[0072] Step S100A: dissolving the supramolecular assembly capable of activating organic phosphorescence as claimed in claims 1 to 4 in water to obtain an aqueous solution of the supramolecular assembly capable of activating organic phosphorescence; and

[0073] Step S200A: performing a UV-visible light absorption titration on the aqueous solution of the supramolecular assembly capable of activating organic phosphorescence to analyze an assembly mode of the supramolecular assembly capable of activating organic phosphorescence.

[0074] In brief, the characterization method is to perform UV-visible absorption titration characterization on the prepared aqueous solution of the supramolecular assembly that can activate organic phosphorescence (i.e., aminobromophenylpyridinium derivative-cucurbituril supramolecular assembly) to analyze the assembly mode of the aminobromophenylpyridinium derivative-cucurbituril supramolecular assembly.

[0075] Characterization of the phosphorus-optical properties of aminobromophenylpyridinium derivative-cucurbituril supramolecular assemblies

[0076] Figure 3B A method for characterizing a supramolecular assembly capable of activating organic phosphorescence, the method comprising the following steps:

[0077] Step S100B: dissolving the supramolecular assembly capable of activating organic phosphorescence as claimed in claims 1 to 4 in water to obtain an aqueous solution of the supramolecular assembly capable of activating organic phosphorescence; and

[0078] Step S200B: Performing a phosphorescence lifetime test on the aqueous solution of the supramolecular assembly capable of activating organic phosphorescence using a phosphorescence spectrometer to analyze a phosphorescence lifetime of the supramolecular assembly capable of activating organic phosphorescence.

[0079] In some embodiments of the present invention, the step S200B further comprises performing a phosphorescence lifetime test on the aqueous solution of the supramolecular assembly capable of activating organic phosphorescence using the phosphorescence spectrometer under viscosity variation conditions.

[0080] In brief, the characterization method is to test the phosphorescence lifetime of the prepared aminobromophenylpyridinium derivative-cucurbituril supramolecular assembly aqueous solution using a phosphorescence spectrometer, and to test the intensity and lifetime of phosphorescence under viscosity variation conditions.

[0081] Characterization of the Phosphorescence Imaging Properties of Aminobromophenylpyridinium Derivatives-Cucurbituril Supramolecular Assemblies in Cells and in Vivo

[0082] In different embodiments, different characterization methods can also be used, such as 1) cellular imaging of aminobromophenylpyridinium derivative-cucurbituril supramolecular assembly; 2) viscosity detection of aminobromophenylpyridinium derivative-cucurbituril supramolecular assembly in cells; and 3) in vivo phosphorescence imaging of aminobromophenylpyridinium derivative-cucurbituril supramolecular assembly.

[0083] Therefore, the present invention also relates to an application of the above-mentioned supramolecular assembly with activatable phosphorescence, and the supramolecular assembly with activatable organic phosphorescence as described above is applied to cell phosphorescence imaging, two-photon phosphorescence imaging, cell viscosity detection, and in vivo phosphorescence imaging.

[0084] The present invention will be described in more detail below with reference to the following examples. However, the present invention is not limited to the following examples and can be implemented with appropriate modifications within the scope consistent with the gist of the present invention. All modifications are included in the technical scope of the present invention.

[0085] Example 1

[0086] In this embodiment, an amino bromophenyl pyridinium derivative is provided as a guest material, and cucurbituril (CB[8]) is used as a host material. The specific method for preparing an organic light-emitting material having an activatable phosphorescent property includes the following steps.

[0087] Experimental group 1: Preparation of guest unit L1-aminobromophenylpyridinium derivative; The synthetic method for preparing guest unit L1 is as follows:

[0088]

[0089] A mixture of 4-(4-bromophenyl)-1-(3-bromopropyl)pyridin-1-ium (71 mg, 0.25 mmol) and tert-butyl (4-(pyridin-4-yl)phenyl)carbamate (100 mg, 0.2 mmol) was dissolved in 10 mL of acetonitrile and heated at 80° C. for 24 hours. The resulting residue was cooled to room temperature and then evaporated to remove the solvent. The crude product was recrystallized from acetonitrile to obtain compound L1 as a white powder.

[0090] Experimental Group 2: Preparation of guest unit L2-aminobromophenylpyridinium derivative; The synthetic method for preparing guest unit L2 is as follows:

[0091]

[0092] The reaction steps are similar to those of guest unit L1 to obtain red solid compound L2.

[0093] See also Figure 4 and Figure 5 , Figure 4 Schematic diagram of the H NMR spectrum of the guest unit L1-aminobromophenylpyridinium derivative of the present invention. Figure 5 Schematic diagram of the H NMR spectrum of the guest unit L2-amino bromophenyl pyridinium derivative of the present invention. The H NMR spectrum of the guest unit L1 prepared in Experimental Group 2 of Example 1 is as follows: Figure 4 As shown; the guest unit L2 prepared in Experimental Group 2 of Example 1 is characterized by the NMR carbon spectrum as shown Figure 5 shown.

[0094] Preparation and characterization of supramolecular assemblies that can activate organic phosphorescence (i.e., aminobromophenylpyridinium derivative-cucurbituril supramolecular assemblies):

[0095] 1) Preparation of aqueous solution of aminobromophenylpyridinium derivative-cucurbituril supramolecular assembly

[0096] The guest unit L1 and guest unit L2 prepared in step 1 are weighed with a cucurbituril (CB[8]) solid sample at a molar ratio of 1:1, dissolved in pure water to obtain a transition solution, and the transition solution is ultrasonically treated for 20 minutes to allow the transition solution to fully dissolve and undergo assembly reaction, thereby obtaining an aqueous solution of the target product, supramolecular assemblies L1C and L2C that can activate organic phosphorescence.

[0097] See also Figure 6 and Figure 7 , Figure 6 Schematic diagram of the absorption spectrum during the supramolecular assembly process of the guest unit L1-aminobromophenylpyridinium derivative and cucurbituril-8 (CB[8]) of the present invention. Figure 7 Schematic diagram of the absorption spectrum during the supramolecular assembly process of the guest unit L2-aminobromophenylpyridinium derivative and cucurbituril-8 (CB[8]) of the present invention. Figure 6 and Figure 7 The concentrations of guest unit L1, guest unit L2 and cucurbituril (CB[8]) in water range from 0 to 1×10 -4 The UV-visible absorption spectrum at 400 M clearly shows the supramolecular interaction process of the supramolecular assemblies L1C and L2C that can activate organic phosphorescence.

[0098] Fig. 9 and Fig. 9 Schematic diagram of the photoemission spectra of L1 (0.1 mM), L2 (0.1 mM) and CB[8] aqueous solutions with concentrations ranging from 0 to 0.09 mM. It can be seen that the phosphorescence emission of the supramolecular assembly that can activate organic phosphorescence gradually increases during the supramolecular process.

[0099] Fig.10 The concentration of supramolecular assembly L1C that can activate organic phosphorescence in aqueous solution at 298K in argon and atmospheric conditions is 10 –4 Schematic diagram of the lifetime spectrum of M.

[0100] Fig.11 Schematic diagram of the photoluminescence spectrum of the supramolecular assembly L1C (50 μM) that can activate organic phosphorescence in water / glycerol mixtures with different viscosities in the emission window of 400-800 nm (excitation wavelength: 400 nm).

[0101] Fig.12 The phosphorescence lifetime spectra of the supramolecular assembly L1C (50 μM) that can activate organic phosphorescence in water / glycerol solutions with different viscosities ranging from 3 to 326 cP.

[0102] Fig.13 The supramolecular assembly L1C (50 μM) that can activate organic phosphorescence responds to various metal ions, reactive oxygen, reactive nitrogen and glycerol.

[0103] The above results indicate that guest unit L1 and guest unit L2 respectively form water-soluble supramolecular assemblies L1C and L2C that can activate organic phosphorescence with cucurbituril (CB[8]), among which the supramolecular assembly L1C that can activate organic phosphorescence exhibits good viscosity-activated phosphorescence emission and shows viscosity response specificity.

[0104] Example 2

[0105] The following experiment is the phosphorescence imaging of the following cells by the supramolecular assembly L1C which can activate organic phosphorescence obtained in Example 1

[0106] The supramolecular assembly L1C can activate organic phosphorescence for lysosomal targeted cell imaging. The specific steps are as follows:

[0107] HeLa cells were co-stained with the phosphor-activatable supramolecular assembly L1C and a commercially available lysosomal targeting dye. Fig.14 , is a schematic diagram of cell lysosome targeting imaging of the supramolecular assembly L1C that can activate phosphorescence according to the present invention. Fig.14 As shown, the organic phosphorescence-activatable supramolecular assembly L1C was shown to accumulate in the lysosomes of HeLa cells, exhibiting phosphorescence emission and showing excellent colocalization with lysosomal green fluorescence.

[0108] Viscosity detection of cells by supramolecular assembly L1C that can activate organic phosphorescence. The specific steps are as follows:

[0109] HeLa cells were incubated with 20 μM dexamethasone and nystatin and then stained with the organophosphor-activatable supramolecular assembly L1C. Fig.15 , is a schematic diagram of cell viscosity detection of the phosphorescence-activatable supramolecular assembly L1C of the present invention under the action of dexamethasone and nystatin. Fig.15 As shown, the red phosphorescence of HeLa cell lysosomes excited by single-photon and two-photon excitation showed significant enhancement under the stimulation of dexamethasone and nystatin. Compared with the control group to which only the supramolecular assembly L1C that can activate organic phosphorescence was added, the phosphorescence intensity of HeLa cells pretreated with dexamethasone and nystatin increased by more than three times. The results show that the supramolecular assembly L1C that can activate organic phosphorescence can image the dynamic changes of lysosomal viscosity under the influence of dexamethasone and nystatin in real time.

[0110] The supramolecular assembly L1C can activate organic phosphorescence for time-resolved imaging of cells. The specific steps are as follows:

[0111] HeLa cells were incubated with the supramolecular assembly L1C (50 μM), which can activate organic phosphorescence, for 6 hours. After incubation, the cells were washed three times with PBS. Phosphorescence cell images were then obtained using phosphorescence lifetime imaging microscopy. Fig.16 , which is the cell time-resolved imaging of the phosphorescence-activatable supramolecular assembly L1C of the present invention, such as Fig.16 As shown, long-lived phosphorescence signals with lifetimes exceeding 1 ms can be clearly detected, indicating that the supramolecular assembly L1C that can activate organic phosphorescence is an effective probe to eliminate short-lived autofluorescence in the background.

[0112] Example 3

[0113] The following experiment is the phosphorescence imaging of mice by the supramolecular assembly L1C that can activate organic phosphorescence obtained in Example 1

[0114] The supramolecular assembly L1C that can activate organic phosphorescence is used to perform phosphorescence imaging of mice. The specific steps are as follows:

[0115] Mice were divided into two groups and injected with lipopolysaccharide in their abdomen to induce viscosity changes. In the first group, the supramolecular assembly L1C (0.3 mM) that can activate organic phosphorescence was intraperitoneally administered as a negative control. The second group received an intraperitoneal injection of lipopolysaccharide (100 μL, 1 mg / mL) and then an intraperitoneal injection of supramolecular assembly L1C (0.3 mM) that can activate organic phosphorescence 24 hours later. Fig.17 , is a schematic diagram of mouse phosphorescence imaging and fluorescence imaging of the supramolecular assembly L1C that can activate phosphorescence of the present invention. Fig.17 As shown, LPS-treated mice exhibited 2.7-fold higher phosphorescence intensity compared with the control group injected only with the phosphorescent-activatable supramolecular assembly L1C, indicating a significant change in viscosity under LPS-induced inflammatory conditions.

[0116] The present invention provides a supramolecular assembly capable of activating phosphorescence, which is used for organelle targeted imaging, cell phosphorescence imaging and sensing, and in vivo phosphorescence imaging and sensing. In addition, the supramolecular assembly capable of activating phosphorescence provided by the present invention is constructed based on the supramolecular assembly effect between an aminobromophenylpyridinium derivative and cucurbituril-8 (CB[8]), that is, the aminobromophenylpyridinium derivative is embedded as a guest unit in the cavity of the ring structure of the cucurbituril-8 (as a main unit), thereby forming the supramolecular assembly capable of activating organic phosphorescence. The amine unit in the aminobromophenylpyridinium derivative serves as a phosphorescence regulating site to regulate the wavelength and intensity of phosphorescence emission, and the supramolecular assembly capable of activating organic phosphorescence is a new organic phosphorescent material with a maximum emission wavelength exceeding 600nm, which is non-toxic, has good biocompatibility, and can be used for biomedical applications of cells and living bodies. Furthermore, the present invention provides a method for preparing a supramolecular assembly capable of activating phosphorescence, which has a simple synthesis route, high reaction efficiency, high yield, and high industrial application prospects. Finally, the present invention provides a method for characterizing a supramolecular assembly capable of activating phosphorescence, which is used to test and analyze the assembly mode, phosphorescence intensity and lifetime of the supramolecular assembly capable of activating phosphorescence, and the application results of cell and living body phosphorescence imaging.

[0117] Although the present invention is disclosed as above with the above preferred embodiments, it is not intended to limit the present invention. Any person skilled in the art may make some changes and modifications without departing from the spirit and scope of the present invention. Therefore, the scope of patent protection of the present invention shall be subject to the scope of the patent application attached to this specification. The present invention is not limited to any of the above embodiments or features. The present invention may include various additions or modifications to the described embodiments.

Claims

1. A supramolecular assembly capable of activating organic phosphorescence, Features: The supramolecular assembly capable of activating organic phosphorescence comprises cucurbituril-8 as a main unit and an aminobromophenylpyridinium derivative of formula (I) as a guest unit, wherein the guest unit is embedded in the cavity of the ring structure of the main unit through supramolecular interaction to form the supramolecular assembly capable of activating organic phosphorescence. Among them, R 1 Selected from N(Me)Boc, OMe, NHMe, OBoc, One of, m is selected from an integer between 0 and 20, R 2 One selected from F, Cl, Br and I, and n is an integer selected from 0 to 18.

2. A method for preparing a supramolecular assembly capable of activating organic phosphorescence, wherein the supramolecular assembly capable of activating organic phosphorescence has cucurbituril-8 as a main unit and an aminobromophenylpyridinium derivative of formula (I) as a guest unit, wherein the guest unit is embedded in the cavity of the ring structure of the main unit through supramolecular interaction to form the supramolecular assembly capable of activating organic phosphorescence, Features: The preparation method comprises the following steps: Step S01: providing an amino bromophenyl pyridinium derivative, wherein a reaction mixture formed by 4-(4-bromophenyl)-1-(3-bromopropyl)pyridin-1-ium and a phenylpyridine derivative is dissolved in acetonitrile to obtain an amino bromophenyl pyridinium derivative represented by the following formula (I), and the reaction chemical formula is as follows: Where R 1 Selected from N(Me)Boc, One of OMe and NHMe. Step S02: dissolving the aminobromophenylpyridinium derivative and cucurbituril-8 (CB[8]) solid sample in an aqueous solution and subjecting the mixture to an ultrasonic treatment to obtain the supramolecular assembly capable of activating organic phosphorescence.

3. The preparation method according to claim 2, Features: The 4-(4-bromophenyl)-1-(3-bromopropyl)pyridin-1-ium and the phenylpyridine derivative were dissolved in acetonitrile at a ratio of 1:

1.

4. The preparation method according to claim 2, Features: The aminobromophenylpyridinium derivative and the cucurbituril-8 solid sample are dissolved in the aqueous solution at a ratio of 1:

1.

5. The preparation method according to claim 2, Features: The concentration of the amino bromophenyl pyridinium is 2.0×10 -5 M -1 , the concentration of cucurbituril-8 is 0-3.0×10 -5 M -1 .

6. A method for characterizing supramolecular assemblies that can activate organic phosphorescence, Features: The method comprises the following steps: Step S100A: dissolving the supramolecular assembly capable of activating organic phosphorescence as claimed in claims 1 to 4 in water to obtain an aqueous solution of the supramolecular assembly capable of activating organic phosphorescence; and Step S200A: performing a UV-visible light absorption titration on the aqueous solution of the supramolecular assembly capable of activating organic phosphorescence to analyze an assembly mode of the supramolecular assembly capable of activating organic phosphorescence.

7. A method for characterizing supramolecular assemblies that can activate organic phosphorescence. Features: The method comprises the following steps: Step S100B: dissolving the supramolecular assembly capable of activating organic phosphorescence as claimed in claims 1 to 4 in water to obtain an aqueous solution of the supramolecular assembly capable of activating organic phosphorescence; and Step S200B: Performing a phosphorescence lifetime test on the aqueous solution of the supramolecular assembly capable of activating organic phosphorescence using a phosphorescence spectrometer to analyze a phosphorescence lifetime of the supramolecular assembly capable of activating organic phosphorescence.

8. The characterization method according to claim 7, Features: The step S200B further includes performing a phosphorescence lifetime test on the aqueous solution of the supramolecular assembly capable of activating organic phosphorescence using the phosphorescence spectrometer under the condition of viscosity variation.

Citation Information

Cited By

  • Phenyl pyridinium salt derivative G, room-temperature phosphorescent supramolecular gel as well as preparation method and application of room-temperature phosphorescent supramolecular gel

    CN122145435A